3: Open Source, Open Science
As the series nears its midway point we are learning about DNDi’s Open Synthesis Network.
As the series nears its midway point, we are going open source. First we’ll talk to Ben Perry and Andrea Vernall about DNDi’s Open Synthesis Network for drug discovery, and then we’ll venture into the academy to speak with one of the students contributing to the Network. Information wants to be free, man, so hit play and learn a thing or two!
is the Discovery Open Innovation Leader for DNDi. He can be found on twitter at @MrBenGP
is a Senior Lecturer in the Department of Chemistry at the University of Otago. She can be found on Twitter at @andreav_otago
is an MRes Drug Discovery and Development Researcher at Imperial College London.
Mentioned in the episode
• the DNDi Open Synthesis Network
• the open source philosophy and the open science philosophy
• ‘Warhead’ molecules in cancer therapy
If you have thoughts on anything you heard in this episode and want to share them or contribute to the magazine, then drop me an email at [email protected]
Log in or register to gain full unlimited access to all content on the The Medicine Maker site. It’s FREE!